跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
H-7A
首页
药物
H-7A
H-7A
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US 7247738 B2
申请人: DABUR INDIA LTD
优先权: 2002
US
4 件公开
POLYMORPHS OF AND SYNTHETIC PROCESS FOR AN AZA-TETRACYCLIC OXAZEPINE INHIBITOR OF KRAS-G12D
WO 2025111586 A1
申请人: GENENTECH INC
优先权: 2023
CN
WO
2 件公开
Melanocortin receptor ligands
US 7132539 B2
申请人: PROCTER & GAMBLE
优先权: 2003
US
2 件公开
Selected CGRP antagonists, process for their preparation as well as their use as medicaments
EP 1770086 A1
申请人: BOEHRINGER INGELHEIM PHARMA
优先权: 2005
EP
Method for stereoselective synthesis of bicyclical heterocycles
EP 2289881 A1
申请人: BOEHRINGER INGELHEIM INT
优先权: 2009
EP
4,5-Diamino-3-Halo-2-Hydroxybenzoic Acid Derivatives and Preparations Thereof
US 2012101157 A1
申请人: LEE AN-RONG
优先权: 2011
US
SUBSTITUTED HETEROARYL 2',3',7',7A'-TETRAHYDROSPIRO[PYRROLE-3,6'-PYRROLO[1,2-C]IMIDAZOLE]-1',2(1H,5'H)-DIONE
US 2013053410 A1
申请人: BARTKOVITZ DAVID JOSEPH
优先权: 2012
US
Method for preparing lurasidone with high purity and high yield
CN 106146486 A
申请人: SHANGHAI PHARMACEUTICALS HOLDING CO LTD
优先权: 2015
CN
RECHARGEABLE METAL-OXYGEN CELLS
EP 3116052 A1
申请人: BASF SE
优先权: 2015
EP
Method for preparing benzofuran-2 (3H) ketone through catalytic dehydrogenation
CN 115141168 A
申请人: DALIAN INST CHEM & PHYSICS CAS
优先权: 2021
CN
第 1 / 2 页
上一页
下一页
药物
反馈